I agree sjacobs26. IMO, there is no way you see a BO offer for anything more than 1000% current share price (i.e., $4.55 right now), even though we all know the company is likely worth far, far more.

Solution? We desperately need organic SP appreciation. I believe some combination of easing financial concerns and great cancer data might get it there.